Document Type: Original Research

Authors

1 Associate Professor, Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 MSc, Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Introduction: The determination of patient’s absorbed dose is the first step of radiation protection which depends on the quantification of organ activity in nuclear medicine. The aim of the present study was to determine the absorbed dose by patient’s uterus following myocardial perfusion scan with 99mTC-sestamibi using Theroluminescnce dosimetry (TLD) and conjugate-view methods.
Material and Method: In this study, each patient was injected 15 to 20 mCi (based on their weight) of 99mTC-sestamibi. Myocardial perfusion scan from twenty two patients (females) were acquired by gamma camera at 15, 60 and 90 minutes after 99mTC-sestamibi injection. To determine the amount of activity in uterus, conjugate view method was applied on images. Then, MIRD equation was used to estimate absorbed dose in uterus of patients. Moreover, uterus absorbed dose was determined using TLD method. At the end, absorbed dose values obtained in conjugate view method were compared with the data obtained from TLD method.
Results: The average amount of uptake for 99mTC-sestamibi by heart was calculated 3.077±0.067 percent of injected dose. The uterus activity at the intervals of 15, 60 and 90 minutes after injection of 99mTC-sestamibi was 0.044±0.015, 0.031±0.014 and 0.026±0.013 mCi, repectively. The uterus absorbed dose per unit of injected activity (mGy/MBq × 10−4) obtained 5.258±0.500 using TLD method.
Conclusion: The results of this study were in good agreement with similar studies. Dosimetry using TLD, in comparison with the conjugate view method, demonstrates more accurate results.

Keywords

  1. Moslehi M, Shanei A, Hakimian SM, Mahmoudi G, Baradaran-Ghahfarokhi M. (99m)Tc-Phytate Lymphoscintigraphy for Detection of Sentinel Node: Preliminary Results of the First Year’s Clinical Experience in Isfahan, Iran. J Med Signals Sens. 2015;5:69-74. PubMed PMID: 25709943. PubMed PMCID: 4335147.
  2. Afshin M, Shanei A, Moslehi M, Rastaghi S. Estimating the Activity of Heart, Liver and Kidneys in Myocardial Perfusion Scan with 99mTC-MIBI Using Conjugate View Method. Isfahan Medical School Journal. 2015;33:983-91.
  3. Pereira JM, Stabin MG, Lima FR, Guimaraes MI, Forrester JW. Image quantification for radiation dose calculations--limitations and uncertainties. Health Phys. 2010;99:688-701. doi.org/10.1097/HP.0b013e3181e28cdb. PubMed PMID: 20938240. PubMed PMCID: 2954504.
  4. Pirdomooie S, Moslehi M, Shanei A. Determination of Absorbed dose of patients organs under kidney Scintigraphy by using the MIRD Dosimetry method. ISMJ. 2016;19:425-34. doi.org/10.18869/acadpub.ismj.19.3.425.
  5. Jonsson L, Ljungberg M, Strand SE. Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom. J Nucl Med. 2005;46:1679-86. PubMed PMID: 16204718.
  6. Shanei A, Afshin M, Moslehi M, Rastaghi S. Estimation of Organ Activity using Four Different Methods of Background Correction in Conjugate View Method. J Med Signals Sens. 2015;5:253-8. PubMed PMID: 26955568. PubMed PMCID: 4759842.
  7. Stabin MG, Tagesson M, Thomas SR, Ljungberg M, Strand SE. Radiation dosimetry in nuclear medicine. Appl Radiat Isot. 1999;50:73-87. doi.org/10.1016/S0969-8043(98)00023-2. PubMed PMID: 10028629.
  8. Thomas SR. From the SNM MIRD committee. Journal of Nuclear Medicine. 2007;48:33N-4N.
  9. Kron T. Thermoluminescence dosimetry and its applications in medicine--Part 1: Physics, materials and equipment. Australas Phys Eng Sci Med. 1994;17:175-99. PubMed PMID: 7872900.
  10. Sahini M, Hossain I, Saeed M, Wagiran H. Thermoluminescence of LiF: Mg, Ti (TLD 100) Subject to 1.25 Mega Electron Volt Gamma Radiotherapy. National Academy Science Letters. 2015;38:365-7. doi.org/10.1007/s40009-015-0351-y.
  11. Rivera T. Thermoluminescence in medical dosimetry. Appl Radiat Isot. 2012;71:30-4. doi.org/10.1016/j.apradiso.2012.04.018. PubMed PMID: 22633888.
  12. Mohammadi K, Sarraf Maamory R, Mohammadi R, Mosavi Zarandi A. Production dosimeter LiF: Mg, Ti and comparison its responses with dosimeter LiF: Mg, Ti (TLD-100) in Harshaw company against of gamma rays. Iranian Journal of Physics Research. 2010;9:321-7.
  13. Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:37S-61S. PubMed PMID: 10025848.
  14. Durand E, Prigent A. The basics of renal imaging and function studies. Q J Nucl Med. 2002;46:249-67. PubMed PMID: 12411866.
  15. Buijs WC, Siegel JA, Boerman OC, Corstens FH. Absolute organ activity estimated by five different methods of background correction. J Nucl Med. 1998;39:2167-72. PubMed PMID: 9867163.
  16. Sydoff M. Activity quantification of planar gamma camera images. 2007.
  17. Jentzen W, Schneider E, Freudenberg L, Eising EG, Gorges R, Muller SP, et al. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer. Nucl Med Commun. 2006;27:669-76. doi.org/10.1097/00006231-200608000-00009. PubMed PMID: 16829767.
  18. Basu S, Abhyankar A. Role of SPECT/CT, versus traditional practices, in individualizing treatment of thyroid carcinoma. J Nucl Med. 2012;53:1819. PubMed PMID: 23042936.
  19. Sorenson JA. Methods for quantitating radioactivity, in vivo, by external counting measurements. Madison: University of Wisconsin-Madison; 1971.
  20. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538-46. PubMed PMID: 8772664.
  21. Helal N. Patient organs dose calculations in nuclear medicine. Int J Res Rev Appl Sci. 2012;11:153-61.
  22. Stabin MG, Stubbs J, Toohey R. Radiation dose estimates for radiopharmaceuticals: Division of Industrial and Medical Nuclear Safety, Office of Nuclear Material Safety and Safeguards, US Nuclear Regulatory Commission; 1996.
  23. Sahebnasagh A, Adinehvand K, Azadbakht B. Determination and comparison of absorbed dose of ovaries and uterus in heart scan from TC-99 m, by three methods: TLD measurement, MCNP simulation and MIRD calculation and estimation of its risks. Res J Appl Sci Eng Technol. 2012;4:4572-5.
  24. Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. J Nucl Med. 2008;49:1555-63. doi.org/10.2967/jnumed.108.052241. PubMed PMID: 18765586.